(Q98568078)
Statements
Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet's disease: results from a large real-world observational study (English)
Yasuo Suzuki
Takashi Hagiwara
Mariko Kobayashi
Kazuo Morita
Tomoyo Shimamoto
Toshifumi Hibi
20 August 2020
1 reference